Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1

Digoxin inhibits development of hypoxic pulmonary hypertension in mice

(2012) E. M. Abud et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinaseThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.

(2010) David F. Meoli et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Emerging therapies for the treatment of pulmonary hypertension

(2010) Kurt R. Stenmark et al.   Pediatric Critical Care Medicine

Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1α in Melanoma Cells

(2010) Francesca Spinella et al.   PLoS One

Nox5 and the Regulation of Cellular Function

(2009) David J.R. Fulton   ANTIOXIDANTS & REDOX SIGNALING

Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells

(2009) Qing-wen Chen et al.   BMC CELL BIOLOGY

Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade

(2009) F. Spinella et al.   CANCER RESEARCH

Endothelin-1 receptor antagonists prevent the development of pulmonary emphysema in rats

(2009) Y. Chen et al.   EUROPEAN RESPIRATORY JOURNAL

Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes

(2007) E. Miles Whitman et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins

(2007) K. Takeda et al.   BLOOD